(Bloomberg) -- Pfizer Inc., the world's biggest
drugmaker, will spend $300 million on research and development in
South Korea in what the government says is the largest such
investment by a foreign entity.
Pfizer Chairman Jeffrey Kindler signed an initial agreement
with South Korea's Ministry of Health and Welfare to cooperate in
the development of drugs and medical technology, the ministry
said today in an e-mailed statement.
Read more at Bloomberg Emerging Markets News
drugmaker, will spend $300 million on research and development in
South Korea in what the government says is the largest such
investment by a foreign entity.
Pfizer Chairman Jeffrey Kindler signed an initial agreement
with South Korea's Ministry of Health and Welfare to cooperate in
the development of drugs and medical technology, the ministry
said today in an e-mailed statement.
Read more at Bloomberg Emerging Markets News
No comments:
Post a Comment